Skip to main content
Clinical Trials/NCT02945475
NCT02945475
Completed
Not Applicable

Neural Mechanisms for Appetitive Responses to High Reward Foods

University of Southern California1 site in 1 country114 target enrollmentFebruary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Appetitive Behavior
Sponsor
University of Southern California
Enrollment
114
Locations
1
Primary Endpoint
Cerebral Blood Flow Response
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study is aimed at understanding neuroendocrine responses to different types of sugars and how this influences feeding behavior among lean, overweight, and obese individuals.

Detailed Description

The investigators have previously combined functional magnetic resonance imaging (fMRI) with hormonal and behavioral assessments to better understand the impacts of glucose and fructose on appetite and its central regulation in humans and have made important observations in lean individuals linking fructose consumption to overeating and obesity. The investigators now propose to expand this work by examining the impacts of glucose and fructose ingested together (sucrose), as occurs in real life, and by examining effects of a common non-nutritive sweetener, sucralose, on brain and appetitive response. The investigators propose a random-order crossover design to determine the effects of caloric and non-nutritive sweeteners among lean, overweight, and obese participants. The investigators will measure circulating levels of hormones involved in satiety signaling, quantify food intake, and measure brain activity using blood-oxygen level dependent and arterial spin labeling methods and functional connectivity analyses.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
March 13, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kathleen Page

Associate Professor of Medicine

University of Southern California

Eligibility Criteria

Inclusion Criteria

  • Age 18-35 years, right-handed, weight change \<2% for at least 3 months prior to participation, no history of diabetes or other significant medical problems, fasting glucose \<126 mg/dl.
  • Lean group: BMI of 19-24.9 kg/m2
  • Obese Group: BMI 30-40 kg/m2
  • Overweight Group: BMI of 25-29.9 kg/m2

Exclusion Criteria

  • Neurological, psychiatric or addiction disorder, fasting glucose ≥126 mg/dl, use of prescription medication (with the exception of contraceptives), tobacco use, contraindications to MRI scanning (detailed in Protection of Human Subjects), fructose intolerance, history of eating disorder, actively trying to lose weight.

Outcomes

Primary Outcomes

Cerebral Blood Flow Response

Time Frame: Sessions 1, 2, 3, 4

Arterial spin labeling with be used to determine brain areas with relative increases or decreases in CBF after ingestion of sucrose, glucose, or sucralose.

Changes of Blood oxygen level-dependent (BOLD) signal responses to food vs non-food cues after ingestion of different types of sugar. BOLD signal responses to food cues will be compared at the level of whole brain and within a priori regions of interest.

Time Frame: Sessions 1, 2, 3, 4

These will be compared between ingestion of drinks and at level of whole brain and in regions of interest

Systemic Metabolite and Hormone Responses

Time Frame: Sessions 1, 2, 3, 4

The effects of sugar ingestion on changes in systemic metabolite (glucose) and hormone (insulin, GLP-1, leptin, ghrelin, peptide YY) levels will be assessed.

Secondary Outcomes

  • Appetite Ratings(Sessions 1, 2, 3, 4)
  • Ad Libitum Food Intake(Sessions 1, 2, 3, 4)
  • Functional Connectivity between regions involved in regulation of food intake(Sessions 1, 2, 3, 4)

Study Sites (1)

Loading locations...

Similar Trials